

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.85218023 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.85218023 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.62124456 |
| 4 | muscle filament sliding (GO:0030049) | 5.55063273 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.55063273 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 5.22060558 |
| 7 | actin-mediated cell contraction (GO:0070252) | 4.64143793 |
| 8 | negative thymic T cell selection (GO:0045060) | 4.45452404 |
| 9 | plasma membrane repair (GO:0001778) | 4.44675747 |
| 10 | negative T cell selection (GO:0043383) | 4.40481016 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.31728047 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29955718 |
| 13 | sarcomere organization (GO:0045214) | 4.23915041 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97329800 |
| 15 | thymic T cell selection (GO:0045061) | 3.95662682 |
| 16 | actin filament-based movement (GO:0030048) | 3.93654300 |
| 17 | T cell migration (GO:0072678) | 3.88832642 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.84606811 |
| 19 | positive T cell selection (GO:0043368) | 3.83483635 |
| 20 | skeletal muscle contraction (GO:0003009) | 3.82006273 |
| 21 | response to interleukin-15 (GO:0070672) | 3.77637405 |
| 22 | leukocyte aggregation (GO:0070486) | 3.74315306 |
| 23 | T cell selection (GO:0045058) | 3.73143365 |
| 24 | skeletal muscle adaptation (GO:0043501) | 3.71575015 |
| 25 | tolerance induction (GO:0002507) | 3.70891592 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47864322 |
| 27 | detection of other organism (GO:0098543) | 3.42479420 |
| 28 | detection of bacterium (GO:0016045) | 3.41504475 |
| 29 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.39068501 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.35024436 |
| 31 | myofibril assembly (GO:0030239) | 3.34981789 |
| 32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.34758868 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 3.34497076 |
| 34 | regulation of T cell tolerance induction (GO:0002664) | 3.28992213 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.27314619 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.27191499 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.25012307 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.25012307 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.25012307 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 3.25012307 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 3.25012307 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.25012307 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20060962 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19767065 |
| 45 | actomyosin structure organization (GO:0031032) | 3.19015894 |
| 46 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18073589 |
| 47 | cellular extravasation (GO:0045123) | 3.14183668 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12943657 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.12885475 |
| 50 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.12221223 |
| 51 | cardiac myofibril assembly (GO:0055003) | 3.12055906 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.08956879 |
| 53 | striated muscle contraction (GO:0006941) | 3.08724015 |
| 54 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06052094 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.05528204 |
| 56 | regulation of p38MAPK cascade (GO:1900744) | 3.04300561 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99306285 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99306285 |
| 59 | striated muscle atrophy (GO:0014891) | 2.98767232 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98156432 |
| 61 | germinal center formation (GO:0002467) | 2.97837402 |
| 62 | growth hormone receptor signaling pathway (GO:0060396) | 2.96508751 |
| 63 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.94114175 |
| 64 | negative regulation of heart growth (GO:0061117) | 2.94114175 |
| 65 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.93731074 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93593283 |
| 67 | positive regulation of histone deacetylation (GO:0031065) | 2.92503296 |
| 68 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.90545402 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86664777 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85517323 |
| 71 | detection of external biotic stimulus (GO:0098581) | 2.84992373 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84059330 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82863266 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82863266 |
| 75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82033101 |
| 76 | cardiac muscle contraction (GO:0060048) | 2.81344605 |
| 77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79448302 |
| 78 | skeletal muscle fiber development (GO:0048741) | 2.78784581 |
| 79 | response to type I interferon (GO:0034340) | 2.77881252 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.77827964 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.77827964 |
| 82 | activated T cell proliferation (GO:0050798) | 2.77410132 |
| 83 | muscle contraction (GO:0006936) | 2.76962293 |
| 84 | immunoglobulin mediated immune response (GO:0016064) | 2.75776103 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.74527361 |
| 86 | negative regulation of innate immune response (GO:0045824) | 2.74450057 |
| 87 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.74406451 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 2.74134723 |
| 89 | positive regulation of myotube differentiation (GO:0010831) | 2.73302182 |
| 90 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73116367 |
| 91 | endodermal cell differentiation (GO:0035987) | 2.71748532 |
| 92 | neutrophil activation (GO:0042119) | 2.71636064 |
| 93 | positive regulation of p38MAPK cascade (GO:1900745) | 2.71285280 |
| 94 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.69970245 |
| 95 | creatine metabolic process (GO:0006600) | 2.69223681 |
| 96 | epithelial cell-cell adhesion (GO:0090136) | 2.67792748 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66747505 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66747505 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66049355 |
| 100 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65914610 |
| 101 | lymphocyte migration (GO:0072676) | 2.65593348 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 2.64522045 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63549867 |
| 104 | mannose metabolic process (GO:0006013) | 2.62340882 |
| 105 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.60569799 |
| 106 | T cell receptor signaling pathway (GO:0050852) | 2.59955446 |
| 107 | apoptotic cell clearance (GO:0043277) | 2.58814396 |
| 108 | cellular response to growth hormone stimulus (GO:0071378) | 2.58579018 |
| 109 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.58335669 |
| 110 | positive regulation of Rap GTPase activity (GO:0032854) | 2.58282186 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.57355052 |
| 112 | regulation of actin filament-based movement (GO:1903115) | 2.56461521 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55772113 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 2.55693019 |
| 115 | regulation of mast cell degranulation (GO:0043304) | 2.54237157 |
| 116 | muscle system process (GO:0003012) | 2.53040043 |
| 117 | Peyers patch development (GO:0048541) | 2.52985843 |
| 118 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.52985843 |
| 119 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.52130106 |
| 120 | regulation of relaxation of muscle (GO:1901077) | 2.51343009 |
| 121 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.51132713 |
| 122 | granulocyte activation (GO:0036230) | 2.50187075 |
| 123 | negative regulation of interleukin-12 production (GO:0032695) | 2.49791118 |
| 124 | cell-substrate junction assembly (GO:0007044) | 2.49320185 |
| 125 | potassium ion import (GO:0010107) | 2.48647906 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.48442178 |
| 127 | negative regulation of stress fiber assembly (GO:0051497) | 2.48371669 |
| 128 | stress fiber assembly (GO:0043149) | 2.48295318 |
| 129 | positive thymic T cell selection (GO:0045059) | 2.47740237 |
| 130 | signal complex assembly (GO:0007172) | 2.46816452 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46252055 |
| 132 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45454447 |
| 133 | regulation of granulocyte differentiation (GO:0030852) | 2.45163830 |
| 134 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.44673081 |
| 135 | basement membrane organization (GO:0071711) | 2.44454420 |
| 136 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43778999 |
| 137 | B cell homeostasis (GO:0001782) | 2.43746884 |
| 138 | myeloid cell activation involved in immune response (GO:0002275) | 2.43208341 |
| 139 | detection of biotic stimulus (GO:0009595) | 2.42829138 |
| 140 | negative regulation of interleukin-6 production (GO:0032715) | 2.41662469 |
| 141 | regulation of extracellular matrix disassembly (GO:0010715) | 2.41226920 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.40598693 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.40396079 |
| 144 | muscle atrophy (GO:0014889) | 2.39756335 |
| 145 | regulation of defense response to virus by virus (GO:0050690) | 2.39561595 |
| 146 | respiratory burst (GO:0045730) | 2.39044743 |
| 147 | carnitine shuttle (GO:0006853) | 2.38953659 |
| 148 | striated muscle adaptation (GO:0014888) | 2.38760775 |
| 149 | negative regulation of cell size (GO:0045792) | 2.38031949 |
| 150 | glomerular basement membrane development (GO:0032836) | 2.34327138 |
| 151 | muscle fiber development (GO:0048747) | 2.33428504 |
| 152 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.32614854 |
| 153 | glomerular epithelial cell development (GO:0072310) | 2.31134735 |
| 154 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.30608705 |
| 155 | positive regulation of tolerance induction (GO:0002645) | 2.29971651 |
| 156 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.29651906 |
| 157 | positive regulation of myoblast differentiation (GO:0045663) | 2.28964608 |
| 158 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.28910128 |
| 159 | myotube cell development (GO:0014904) | 2.28371905 |
| 160 | positive regulation of astrocyte differentiation (GO:0048711) | 2.27138099 |
| 161 | regulation of striated muscle contraction (GO:0006942) | 2.26971879 |
| 162 | cell adhesion mediated by integrin (GO:0033627) | 2.24474329 |
| 163 | collagen fibril organization (GO:0030199) | 2.22298422 |
| 164 | response to muscle activity (GO:0014850) | 2.22255618 |
| 165 | regulation of macrophage cytokine production (GO:0010935) | 2.22250694 |
| 166 | protein heterotrimerization (GO:0070208) | 2.20945024 |
| 167 | focal adhesion assembly (GO:0048041) | 2.20572540 |
| 168 | cell-substrate adherens junction assembly (GO:0007045) | 2.20572540 |
| 169 | relaxation of cardiac muscle (GO:0055119) | 2.20468658 |
| 170 | keratan sulfate catabolic process (GO:0042340) | 2.20137449 |
| 171 | cardiac muscle cell development (GO:0055013) | 2.20124581 |
| 172 | response to inactivity (GO:0014854) | 2.19859957 |
| 173 | syncytium formation (GO:0006949) | 2.19672803 |
| 174 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19475072 |
| 175 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19280733 |
| 176 | glycogen catabolic process (GO:0005980) | 2.17927490 |
| 177 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.16591055 |
| 178 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.16511922 |
| 179 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.14838089 |
| 180 | cardiac cell development (GO:0055006) | 2.14413292 |
| 181 | adherens junction assembly (GO:0034333) | 2.14201699 |
| 182 | regulation of cell communication by electrical coupling (GO:0010649) | 2.12726811 |
| 183 | heart trabecula formation (GO:0060347) | 2.12150460 |
| 184 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.11716135 |
| 185 | response to fluid shear stress (GO:0034405) | 2.11154156 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.10154673 |
| 187 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.08701170 |
| 188 | muscle adaptation (GO:0043500) | 2.07658377 |
| 189 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.07154732 |
| 190 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.06802948 |
| 191 | sodium ion export (GO:0071436) | 2.06046909 |
| 192 | adhesion of symbiont to host cell (GO:0044650) | 2.05988216 |
| 193 | virion attachment to host cell (GO:0019062) | 2.05988216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.26120592 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.12978305 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.04954368 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81244106 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78823473 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57168415 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.30944120 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27399046 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26522156 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26273871 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17050665 |
| 12 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11139938 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06058450 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.03386790 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.99643969 |
| 16 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.98366946 |
| 17 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.98366946 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95971820 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 1.95872032 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.79433282 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77002651 |
| 22 | * MAF_26560356_Chip-Seq_TH2_Human | 1.76975267 |
| 23 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.74668288 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73881155 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73011645 |
| 26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72844064 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72748846 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.70946540 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70463708 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.69546163 |
| 31 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65610211 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64964482 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64849279 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64025318 |
| 35 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.63061989 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58584835 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57541361 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56766426 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53022554 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48122841 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47642132 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47121788 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45727157 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45505496 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45046596 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44686455 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44348421 |
| 48 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44030657 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43271479 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41800239 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40735709 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36278160 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34796959 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33598713 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33119563 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32982642 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31818836 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31446023 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30808062 |
| 60 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30009396 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28007584 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27502415 |
| 63 | * MAF_26560356_Chip-Seq_TH1_Human | 1.26858389 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26570713 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26253153 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25711859 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25044930 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23999399 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22961700 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22266519 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22186703 |
| 72 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21908567 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21545426 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21215975 |
| 75 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20803906 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20270366 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19942304 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19892499 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19732564 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19490601 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18733715 |
| 82 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17627247 |
| 83 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15051623 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14678269 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13378969 |
| 86 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13249592 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13176340 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13091843 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12989489 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12817547 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12409281 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11647593 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11155377 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10562640 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10451163 |
| 96 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10329153 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10285702 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09988782 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08829075 |
| 100 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.08400416 |
| 101 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07478523 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07462257 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07440736 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06268114 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06193864 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03520053 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03264197 |
| 108 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03049409 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01843699 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01705446 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01401440 |
| 112 | * P68_20966046_ChIP-Seq_HELA_Human | 1.01201963 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01028490 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00777718 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99520303 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99029821 |
| 117 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98909243 |
| 118 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98512014 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98031276 |
| 120 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97936399 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97632990 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97476834 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97054612 |
| 124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96616254 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96449859 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95883424 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95883424 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95583504 |
| 129 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95492081 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94218625 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94146279 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93898069 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93690964 |
| 134 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93643215 |
| 135 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92923927 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92805039 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92628217 |
| 138 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92529804 |
| 139 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92482463 |
| 140 | MYC_22102868_ChIP-Seq_BL_Human | 0.92461093 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91358276 |
| 142 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91153376 |
| 143 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90711060 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90279241 |
| 145 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.89631946 |
| 146 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87913728 |
| 147 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87375613 |
| 148 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86696191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.70647109 |
| 2 | MP0000751_myopathy | 3.65343196 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.41711875 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.40258584 |
| 5 | MP0000749_muscle_degeneration | 3.22582417 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.20122427 |
| 7 | MP0005671_abnormal_response_to | 2.78710767 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.67895588 |
| 9 | MP0001800_abnormal_humoral_immune | 2.65497962 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.64511462 |
| 11 | MP0003279_aneurysm | 2.62728277 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.61931765 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.54213472 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.51233437 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.49753697 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.46431734 |
| 17 | MP0005025_abnormal_response_to | 2.43694062 |
| 18 | MP0002419_abnormal_innate_immunity | 2.40488638 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.40477901 |
| 20 | MP0002723_abnormal_immune_serum | 2.31880641 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.29655528 |
| 22 | MP0003646_muscle_fatigue | 2.28834988 |
| 23 | MP0001819_abnormal_immune_cell | 2.26730419 |
| 24 | MP0001958_emphysema | 2.24211785 |
| 25 | MP0000747_muscle_weakness | 2.18469302 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.16454221 |
| 27 | MP0004130_abnormal_muscle_cell | 2.15694525 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 2.13907493 |
| 29 | MP0002106_abnormal_muscle_physiology | 2.13742921 |
| 30 | MP0000733_abnormal_muscle_development | 2.11544636 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 2.06911587 |
| 32 | MP0005275_abnormal_skin_tensile | 2.05577441 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.99946572 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.98778730 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.97756937 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.96888973 |
| 37 | MP0009785_altered_susceptibility_to | 1.96027978 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.93915479 |
| 39 | MP0003866_abnormal_defecation | 1.92535855 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.90804977 |
| 41 | MP0004947_skin_inflammation | 1.87636823 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.86420109 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.84391723 |
| 44 | MP0005330_cardiomyopathy | 1.83165713 |
| 45 | MP0002398_abnormal_bone_marrow | 1.82735461 |
| 46 | MP0005369_muscle_phenotype | 1.79019062 |
| 47 | MP0000716_abnormal_immune_system | 1.78927647 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.77823070 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.77305574 |
| 50 | MP0002405_respiratory_system_inflammati | 1.76910252 |
| 51 | MP0003045_fibrosis | 1.75955856 |
| 52 | MP0006082_CNS_inflammation | 1.73811123 |
| 53 | MP0002269_muscular_atrophy | 1.63863677 |
| 54 | MP0003303_peritoneal_inflammation | 1.60735192 |
| 55 | MP0008260_abnormal_autophagy | 1.60686870 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.58363118 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.57943238 |
| 58 | MP0002972_abnormal_cardiac_muscle | 1.55426225 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.54267381 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.52086586 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.51952809 |
| 62 | MP0001851_eye_inflammation | 1.50083227 |
| 63 | MP0004510_myositis | 1.49205083 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.48238038 |
| 65 | MP0002722_abnormal_immune_system | 1.47788242 |
| 66 | MP0005670_abnormal_white_adipose | 1.47434732 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.45750911 |
| 68 | MP0004272_abnormal_basement_membrane | 1.44746734 |
| 69 | MP0009840_abnormal_foam_cell | 1.41634578 |
| 70 | MP0005451_abnormal_body_composition | 1.40852007 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.40634371 |
| 72 | MP0002132_abnormal_respiratory_system | 1.40517041 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.40452182 |
| 74 | MP0002429_abnormal_blood_cell | 1.38507299 |
| 75 | MP0003091_abnormal_cell_migration | 1.37617301 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.37599589 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.36893519 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.33438895 |
| 79 | MP0000343_altered_response_to | 1.31799757 |
| 80 | MP0002108_abnormal_muscle_morphology | 1.29503543 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.25715054 |
| 82 | MP0001544_abnormal_cardiovascular_syste | 1.23183933 |
| 83 | MP0005385_cardiovascular_system_phenoty | 1.23183933 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.23109218 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.22986736 |
| 86 | MP0003828_pulmonary_edema | 1.21823667 |
| 87 | MP0004381_abnormal_hair_follicle | 1.21446891 |
| 88 | MP0006054_spinal_hemorrhage | 1.19560919 |
| 89 | MP0001873_stomach_inflammation | 1.17783699 |
| 90 | MP0000685_abnormal_immune_system | 1.17301047 |
| 91 | MP0002254_reproductive_system_inflammat | 1.16683476 |
| 92 | MP0003690_abnormal_glial_cell | 1.16491144 |
| 93 | MP0008004_abnormal_stomach_pH | 1.16482087 |
| 94 | MP0004484_altered_response_of | 1.15556111 |
| 95 | MP0008469_abnormal_protein_level | 1.13688627 |
| 96 | MP0004233_abnormal_muscle_weight | 1.13456312 |
| 97 | MP0008775_abnormal_heart_ventricle | 1.13303375 |
| 98 | MP0000767_abnormal_smooth_muscle | 1.12446653 |
| 99 | MP0002933_joint_inflammation | 1.11791996 |
| 100 | MP0000604_amyloidosis | 1.11629612 |
| 101 | MP0004883_abnormal_blood_vessel | 1.10493550 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 1.07964856 |
| 103 | MP0005166_decreased_susceptibility_to | 1.07525268 |
| 104 | MP0000003_abnormal_adipose_tissue | 1.06984882 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 1.05703645 |
| 106 | MP0008961_abnormal_basal_metabolism | 1.04847771 |
| 107 | MP0003329_amyloid_beta_deposits | 1.04351516 |
| 108 | MP0002009_preneoplasia | 1.04000880 |
| 109 | MP0009278_abnormal_bone_marrow | 1.02556832 |
| 110 | MP0009764_decreased_sensitivity_to | 0.97172482 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.97016473 |
| 112 | MP0002168_other_aberrant_phenotype | 0.95997571 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.95913250 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.95888557 |
| 115 | MP0003878_abnormal_ear_physiology | 0.95888557 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.95521252 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.95493612 |
| 118 | MP0005023_abnormal_wound_healing | 0.94849588 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.94528904 |
| 120 | MP0005257_abnormal_intraocular_pressure | 0.94496128 |
| 121 | MP0005310_abnormal_salivary_gland | 0.91250899 |
| 122 | MP0004858_abnormal_nervous_system | 0.89389368 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.88721239 |
| 124 | MP0006138_congestive_heart_failure | 0.88147029 |
| 125 | MP0001790_abnormal_immune_system | 0.87773026 |
| 126 | MP0005387_immune_system_phenotype | 0.87773026 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.87520406 |
| 128 | MP0002971_abnormal_brown_adipose | 0.87033966 |
| 129 | MP0003436_decreased_susceptibility_to | 0.86927376 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.84899526 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.84899526 |
| 132 | MP0005164_abnormal_response_to | 0.84762936 |
| 133 | MP0002006_tumorigenesis | 0.84437556 |
| 134 | MP0001663_abnormal_digestive_system | 0.84020984 |
| 135 | MP0005165_increased_susceptibility_to | 0.83329891 |
| 136 | MP0002128_abnormal_blood_circulation | 0.80946635 |
| 137 | MP0000858_altered_metastatic_potential | 0.79523988 |
| 138 | MP0005508_abnormal_skeleton_morphology | 0.79501641 |
| 139 | MP0001299_abnormal_eye_distance/ | 0.79124727 |
| 140 | MP0003075_altered_response_to | 0.78830581 |
| 141 | MP0003795_abnormal_bone_structure | 0.78136610 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.77881451 |
| 143 | MP0008874_decreased_physiological_sensi | 0.77275883 |
| 144 | MP0002060_abnormal_skin_morphology | 0.77208318 |
| 145 | MP0003448_altered_tumor_morphology | 0.74555091 |
| 146 | MP0000266_abnormal_heart_morphology | 0.73699113 |
| 147 | MP0001835_abnormal_antigen_presentation | 0.72565771 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.72221224 |
| 149 | MP0005390_skeleton_phenotype | 0.70767929 |
| 150 | MP0009763_increased_sensitivity_to | 0.70716039 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.69921892 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.68726940 |
| 153 | MP0001853_heart_inflammation | 0.68397664 |
| 154 | MP0002138_abnormal_hepatobiliary_system | 0.68170757 |
| 155 | MP0010368_abnormal_lymphatic_system | 0.68094039 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.67892756 |
| 157 | MP0000249_abnormal_blood_vessel | 0.66881729 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.66515860 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.65381136 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.62881596 |
| 161 | MP0004808_abnormal_hematopoietic_stem | 0.62765296 |
| 162 | MP0000920_abnormal_myelination | 0.61877896 |
| 163 | MP0002277_abnormal_respiratory_mucosa | 0.58961565 |
| 164 | MP0008569_lethality_at_weaning | 0.57207518 |
| 165 | MP0003453_abnormal_keratinocyte_physiol | 0.56727514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 5.59159566 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.42813660 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.24092499 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.19670147 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.92450748 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.64567518 |
| 7 | Nemaline bodies (HP:0003798) | 4.63467560 |
| 8 | Myositis (HP:0100614) | 4.43315563 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.23160929 |
| 10 | Round ear (HP:0100830) | 4.19454054 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.17389370 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 4.08004713 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.02146191 |
| 14 | Difficulty running (HP:0009046) | 3.94975414 |
| 15 | Increased connective tissue (HP:0009025) | 3.92829478 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 3.86812340 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.77423832 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74932617 |
| 19 | Orchitis (HP:0100796) | 3.74257060 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.71462084 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.68016310 |
| 22 | Myopathic facies (HP:0002058) | 3.67301283 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.64847068 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.55242525 |
| 25 | Prolonged bleeding time (HP:0003010) | 3.52494280 |
| 26 | Aortic aneurysm (HP:0004942) | 3.49847825 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.49502020 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.44083014 |
| 29 | Optic neuritis (HP:0100653) | 3.44083014 |
| 30 | Cerebral aneurysm (HP:0004944) | 3.43962771 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.40467892 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.40466813 |
| 33 | Stomatitis (HP:0010280) | 3.32766785 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.29964198 |
| 35 | Aortic dissection (HP:0002647) | 3.28693931 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.28668381 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.28564057 |
| 38 | Increased IgE level (HP:0003212) | 3.23878202 |
| 39 | Sudden death (HP:0001699) | 3.22108212 |
| 40 | Pustule (HP:0200039) | 3.15891641 |
| 41 | T lymphocytopenia (HP:0005403) | 3.15685546 |
| 42 | Meningitis (HP:0001287) | 3.15224053 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.11942343 |
| 44 | Broad metatarsal (HP:0001783) | 3.11098971 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10203597 |
| 46 | Myoglobinuria (HP:0002913) | 3.05170027 |
| 47 | Protrusio acetabuli (HP:0003179) | 3.04587705 |
| 48 | Recurrent fungal infections (HP:0002841) | 3.04373099 |
| 49 | Frequent falls (HP:0002359) | 3.02046223 |
| 50 | Facial diplegia (HP:0001349) | 3.01807334 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01666597 |
| 52 | Obstructive lung disease (HP:0006536) | 3.01666597 |
| 53 | Difficulty climbing stairs (HP:0003551) | 3.01445968 |
| 54 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.00962333 |
| 55 | Subaortic stenosis (HP:0001682) | 3.00962333 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.98015464 |
| 57 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.97088289 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.95761909 |
| 59 | Vasculitis (HP:0002633) | 2.94289811 |
| 60 | Epistaxis (HP:0000421) | 2.92748200 |
| 61 | Premature rupture of membranes (HP:0001788) | 2.90720868 |
| 62 | Cellulitis (HP:0100658) | 2.82722513 |
| 63 | Ventricular tachycardia (HP:0004756) | 2.80704864 |
| 64 | Calcaneovalgus deformity (HP:0001848) | 2.77465661 |
| 65 | Scapular winging (HP:0003691) | 2.77358094 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.71418718 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.70007312 |
| 68 | Purpura (HP:0000979) | 2.69811102 |
| 69 | Gingivitis (HP:0000230) | 2.69310135 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.68210633 |
| 71 | Encephalitis (HP:0002383) | 2.65984984 |
| 72 | Gingival bleeding (HP:0000225) | 2.65001216 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 2.61010547 |
| 74 | Deformed tarsal bones (HP:0008119) | 2.60733420 |
| 75 | Chest pain (HP:0100749) | 2.59863608 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.58612486 |
| 77 | Increased density of long bones (HP:0006392) | 2.57385207 |
| 78 | Abnormality of T cells (HP:0002843) | 2.55471349 |
| 79 | Colitis (HP:0002583) | 2.53830663 |
| 80 | Papilledema (HP:0001085) | 2.53204904 |
| 81 | Recurrent skin infections (HP:0001581) | 2.52510103 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.51456206 |
| 83 | Spinal rigidity (HP:0003306) | 2.49661821 |
| 84 | Absent phalangeal crease (HP:0006109) | 2.49347762 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.45202915 |
| 86 | Granulocytopenia (HP:0001913) | 2.44038781 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.43101641 |
| 88 | Malignant hyperthermia (HP:0002047) | 2.42459235 |
| 89 | Ankle contracture (HP:0006466) | 2.42096951 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.38525844 |
| 91 | Neck muscle weakness (HP:0000467) | 2.38146465 |
| 92 | Shallow orbits (HP:0000586) | 2.37032502 |
| 93 | Petechiae (HP:0000967) | 2.35344750 |
| 94 | Myotonia (HP:0002486) | 2.33653643 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33064685 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33064685 |
| 97 | Muscle stiffness (HP:0003552) | 2.31192569 |
| 98 | Recurrent viral infections (HP:0004429) | 2.30695345 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.29812102 |
| 100 | Recurrent bronchitis (HP:0002837) | 2.29297772 |
| 101 | Urticaria (HP:0001025) | 2.24434152 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.24309830 |
| 103 | Leukocytosis (HP:0001974) | 2.23494546 |
| 104 | Aneurysm (HP:0002617) | 2.23327427 |
| 105 | Lipoatrophy (HP:0100578) | 2.22919543 |
| 106 | Increased IgM level (HP:0003496) | 2.21447413 |
| 107 | Gowers sign (HP:0003391) | 2.21422597 |
| 108 | Slender build (HP:0001533) | 2.20848392 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 2.20664856 |
| 110 | Lymphopenia (HP:0001888) | 2.18696722 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.17513151 |
| 112 | Pulmonary embolism (HP:0002204) | 2.17013725 |
| 113 | Hemoptysis (HP:0002105) | 2.16492859 |
| 114 | IgM deficiency (HP:0002850) | 2.16240520 |
| 115 | Rhabdomyolysis (HP:0003201) | 2.15836381 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 2.15024440 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 2.14051381 |
| 118 | Abnormal finger flexion creases (HP:0006143) | 2.13708741 |
| 119 | Arterial tortuosity (HP:0005116) | 2.13456702 |
| 120 | Vascular tortuosity (HP:0004948) | 2.11849564 |
| 121 | Papilloma (HP:0012740) | 2.11408990 |
| 122 | Verrucae (HP:0200043) | 2.11408990 |
| 123 | Abnormality of the calcaneus (HP:0008364) | 2.10486506 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 2.10006264 |
| 125 | Tarsal synostosis (HP:0008368) | 2.09897381 |
| 126 | Systemic lupus erythematosus (HP:0002725) | 2.09380731 |
| 127 | Hypoplastic ischia (HP:0003175) | 2.08161241 |
| 128 | Generalized muscle weakness (HP:0003324) | 2.06284593 |
| 129 | Abnormal platelet volume (HP:0011876) | 2.04618044 |
| 130 | Emphysema (HP:0002097) | 2.03794397 |
| 131 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03172263 |
| 132 | Atrial fibrillation (HP:0005110) | 2.02935594 |
| 133 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02880445 |
| 134 | Episodic fever (HP:0001954) | 2.02342547 |
| 135 | Arterial thrombosis (HP:0004420) | 2.02342204 |
| 136 | Limb-girdle muscle atrophy (HP:0003797) | 2.02132678 |
| 137 | Eosinophilia (HP:0001880) | 2.01493861 |
| 138 | Fatigable weakness (HP:0003473) | 2.00528150 |
| 139 | Abnormality of the neuromuscular junction (HP:0003398) | 2.00528150 |
| 140 | Restrictive lung disease (HP:0002091) | 1.98057571 |
| 141 | Amyloidosis (HP:0011034) | 1.95880651 |
| 142 | Dilatation of the ascending aorta (HP:0005111) | 1.95703069 |
| 143 | Mitral valve prolapse (HP:0001634) | 1.95305018 |
| 144 | Obstructive sleep apnea (HP:0002870) | 1.94541418 |
| 145 | Atrophic scars (HP:0001075) | 1.92848028 |
| 146 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90267883 |
| 147 | Hypochromic anemia (HP:0001931) | 1.90257849 |
| 148 | Osteomyelitis (HP:0002754) | 1.89719629 |
| 149 | Slow saccadic eye movements (HP:0000514) | 1.89292549 |
| 150 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.87968806 |
| 151 | Synostosis involving bones of the feet (HP:0009140) | 1.87968806 |
| 152 | Primary atrial arrhythmia (HP:0001692) | 1.87917024 |
| 153 | Bulbar palsy (HP:0001283) | 1.87229470 |
| 154 | Hematochezia (HP:0002573) | 1.87032440 |
| 155 | Menorrhagia (HP:0000132) | 1.86593482 |
| 156 | Premature loss of primary teeth (HP:0006323) | 1.86523535 |
| 157 | Cervical subluxation (HP:0003308) | 1.85719288 |
| 158 | Hip contracture (HP:0003273) | 1.84766210 |
| 159 | Acne (HP:0001061) | 1.84031554 |
| 160 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83982400 |
| 161 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83982400 |
| 162 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83982400 |
| 163 | Dilated cardiomyopathy (HP:0001644) | 1.83624521 |
| 164 | Polygenic inheritance (HP:0010982) | 1.81954391 |
| 165 | Joint swelling (HP:0001386) | 1.81891708 |
| 166 | Glomerulopathy (HP:0100820) | 1.81486637 |
| 167 | Abnormality of eosinophils (HP:0001879) | 1.81238377 |
| 168 | Glomerulonephritis (HP:0000099) | 1.79863897 |
| 169 | Spondylolisthesis (HP:0003302) | 1.79681684 |
| 170 | Bundle branch block (HP:0011710) | 1.79451599 |
| 171 | Hyperkalemia (HP:0002153) | 1.78825358 |
| 172 | Hyperlipoproteinemia (HP:0010980) | 1.78156078 |
| 173 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78101108 |
| 174 | Mucopolysacchariduria (HP:0008155) | 1.78101108 |
| 175 | Loss of speech (HP:0002371) | 1.78018252 |
| 176 | Supraventricular arrhythmia (HP:0005115) | 1.77442969 |
| 177 | Supraventricular tachycardia (HP:0004755) | 1.73360023 |
| 178 | Proximal amyotrophy (HP:0007126) | 1.72354575 |
| 179 | Peritonitis (HP:0002586) | 1.71739162 |
| 180 | Abnormality of the ischium (HP:0003174) | 1.68210762 |
| 181 | Lower limb amyotrophy (HP:0007210) | 1.66675678 |
| 182 | Abnormality of the nasal mucosa (HP:0000433) | 1.65395432 |
| 183 | Muscular dystrophy (HP:0003560) | 1.63632087 |
| 184 | Easy fatigability (HP:0003388) | 1.63090271 |
| 185 | Bladder diverticulum (HP:0000015) | 1.61938970 |
| 186 | Ventricular arrhythmia (HP:0004308) | 1.61914880 |
| 187 | Fragile skin (HP:0001030) | 1.61297795 |
| 188 | Prolonged QT interval (HP:0001657) | 1.61294489 |
| 189 | Mesomelia (HP:0003027) | 1.60562113 |
| 190 | Wrist flexion contracture (HP:0001239) | 1.59950995 |
| 191 | Weak cry (HP:0001612) | 1.59618736 |
| 192 | Radial bowing (HP:0002986) | 1.58911213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.23753042 |
| 2 | TRIB3 | 4.52355681 |
| 3 | PRPF4B | 3.10918099 |
| 4 | RIPK4 | 2.99763285 |
| 5 | OBSCN | 2.82500584 |
| 6 | PKN2 | 2.67907022 |
| 7 | PHKG1 | 2.54074973 |
| 8 | PHKG2 | 2.54074973 |
| 9 | PIK3CG | 2.53888724 |
| 10 | DMPK | 2.44885315 |
| 11 | FES | 2.42358350 |
| 12 | ERN1 | 2.13249780 |
| 13 | MYLK | 2.12775531 |
| 14 | TAOK3 | 2.08125957 |
| 15 | LMTK2 | 2.07114544 |
| 16 | TXK | 2.03262984 |
| 17 | TNK2 | 1.95138705 |
| 18 | EPHB1 | 1.91254620 |
| 19 | SIK1 | 1.90247035 |
| 20 | TGFBR2 | 1.90113921 |
| 21 | PTK6 | 1.69976978 |
| 22 | RIPK1 | 1.64535787 |
| 23 | PDGFRA | 1.57630843 |
| 24 | LRRK2 | 1.53811043 |
| 25 | MAP3K10 | 1.52843566 |
| 26 | JAK1 | 1.52626437 |
| 27 | SYK | 1.49494416 |
| 28 | IRAK4 | 1.45678883 |
| 29 | MARK2 | 1.35891501 |
| 30 | EEF2K | 1.32559894 |
| 31 | PIK3CA | 1.30228972 |
| 32 | TYK2 | 1.29818179 |
| 33 | FGFR4 | 1.27610421 |
| 34 | MAP4K1 | 1.25662530 |
| 35 | MAP3K11 | 1.22154332 |
| 36 | MAP3K7 | 1.20483553 |
| 37 | MAP2K3 | 1.19048656 |
| 38 | LCK | 1.18924047 |
| 39 | FGFR3 | 1.15944566 |
| 40 | TRPM7 | 1.15570964 |
| 41 | SIK3 | 1.14807044 |
| 42 | EPHA3 | 1.14399990 |
| 43 | MAP3K1 | 1.12759165 |
| 44 | CAMKK1 | 1.07988754 |
| 45 | DDR2 | 1.07734224 |
| 46 | LYN | 1.01304427 |
| 47 | JAK3 | 0.98069616 |
| 48 | MAPK12 | 0.97421783 |
| 49 | MAPK7 | 0.97377574 |
| 50 | TBK1 | 0.97196814 |
| 51 | SIK2 | 0.96217772 |
| 52 | NEK9 | 0.96098607 |
| 53 | ILK | 0.95974878 |
| 54 | PDK1 | 0.94504454 |
| 55 | STK10 | 0.93508776 |
| 56 | MOS | 0.93433794 |
| 57 | BMX | 0.92427239 |
| 58 | TEC | 0.91807945 |
| 59 | ROCK1 | 0.90709070 |
| 60 | SMG1 | 0.89821446 |
| 61 | PAK3 | 0.89068190 |
| 62 | KSR2 | 0.88132368 |
| 63 | EPHB2 | 0.87242020 |
| 64 | DYRK1B | 0.84251658 |
| 65 | CAMK1G | 0.83706921 |
| 66 | TAOK1 | 0.82787328 |
| 67 | PRKCH | 0.82535302 |
| 68 | PAK2 | 0.81667804 |
| 69 | MAPKAPK3 | 0.80095300 |
| 70 | PAK4 | 0.79786075 |
| 71 | CAMK1D | 0.77655499 |
| 72 | PRKD1 | 0.76764157 |
| 73 | CSK | 0.75260671 |
| 74 | MAP2K2 | 0.73504897 |
| 75 | MAP3K13 | 0.72459772 |
| 76 | FGR | 0.69257765 |
| 77 | ITK | 0.69245841 |
| 78 | ROCK2 | 0.69174259 |
| 79 | HCK | 0.68846271 |
| 80 | PDGFRB | 0.67763484 |
| 81 | MAPK15 | 0.66029167 |
| 82 | CDC42BPA | 0.65826498 |
| 83 | TESK2 | 0.65590622 |
| 84 | PRKAA2 | 0.65011123 |
| 85 | PTK2 | 0.64580360 |
| 86 | STK38 | 0.64178596 |
| 87 | JAK2 | 0.63192034 |
| 88 | PRKCQ | 0.62568335 |
| 89 | MUSK | 0.61883537 |
| 90 | PDK4 | 0.61525766 |
| 91 | PDK3 | 0.61525766 |
| 92 | LATS1 | 0.60282689 |
| 93 | FYN | 0.60118071 |
| 94 | RET | 0.59787851 |
| 95 | FER | 0.58617561 |
| 96 | TAOK2 | 0.58586231 |
| 97 | ZAP70 | 0.58221014 |
| 98 | CAMKK2 | 0.57405944 |
| 99 | TIE1 | 0.57176184 |
| 100 | IRAK3 | 0.56156995 |
| 101 | RPS6KL1 | 0.55907314 |
| 102 | RPS6KC1 | 0.55907314 |
| 103 | PRKD2 | 0.55683204 |
| 104 | FRK | 0.54569326 |
| 105 | PIM1 | 0.53488112 |
| 106 | MAPK11 | 0.53223164 |
| 107 | MAP3K3 | 0.52297338 |
| 108 | PTK2B | 0.50788731 |
| 109 | HIPK2 | 0.50728027 |
| 110 | CHUK | 0.49859629 |
| 111 | STK24 | 0.49842191 |
| 112 | CDK12 | 0.49420010 |
| 113 | MAPK4 | 0.48699273 |
| 114 | KIT | 0.48457483 |
| 115 | FLT3 | 0.48363967 |
| 116 | BLK | 0.47517414 |
| 117 | TYRO3 | 0.46403638 |
| 118 | IKBKE | 0.45884510 |
| 119 | KDR | 0.45432014 |
| 120 | PDK2 | 0.45347439 |
| 121 | MTOR | 0.45271491 |
| 122 | SGK3 | 0.44462589 |
| 123 | ARAF | 0.44407475 |
| 124 | BTK | 0.43598503 |
| 125 | IRAK1 | 0.43465115 |
| 126 | RPS6KA6 | 0.42598948 |
| 127 | YES1 | 0.41282039 |
| 128 | MAP3K14 | 0.40940234 |
| 129 | FGFR1 | 0.40301679 |
| 130 | SGK2 | 0.39682267 |
| 131 | MAP2K1 | 0.39644479 |
| 132 | GRK6 | 0.39471810 |
| 133 | CSF1R | 0.39329274 |
| 134 | PDPK1 | 0.38606523 |
| 135 | PRKAA1 | 0.37825464 |
| 136 | CDK6 | 0.37497928 |
| 137 | DAPK3 | 0.36716666 |
| 138 | ICK | 0.35173388 |
| 139 | FGFR2 | 0.35079937 |
| 140 | IKBKB | 0.34706680 |
| 141 | PRKD3 | 0.34615652 |
| 142 | NLK | 0.34370214 |
| 143 | MARK3 | 0.34169347 |
| 144 | GRK5 | 0.33748435 |
| 145 | RPS6KA2 | 0.32043906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.67001210 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.62025170 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.31686746 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14395962 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.02853222 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01400709 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97285958 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 1.92062068 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91754348 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83163492 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.75302975 |
| 12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.63137278 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57531789 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56592977 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51102742 |
| 16 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.40765751 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.39696678 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.35908254 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32327383 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.32269347 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30241700 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29779194 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27438772 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27146596 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25589445 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23384393 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22113589 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21795993 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21419087 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15998567 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15249715 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.14539865 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.13740289 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11342101 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09727861 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08767959 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07140245 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06818885 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.05000516 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.04876424 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03522891 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03431943 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.03310382 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.02099145 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00785422 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99607885 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99110999 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98375560 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.95943330 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.95899615 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94677612 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92407178 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92196171 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91858196 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.90693523 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89607882 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89259891 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89257912 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.88078710 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88031199 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85712140 |
| 62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83012967 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82961911 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82321463 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82227910 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82148896 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.81909279 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80652398 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80601104 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80032683 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79864513 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79322954 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79283444 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78666673 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78322245 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78004432 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.77660987 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77637519 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.76765671 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75982688 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75080110 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74988632 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74479195 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74065953 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.73045891 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.72817197 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72244757 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72082010 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71018063 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.70361672 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70272798 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69258288 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68829845 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68464400 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68198069 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.67226240 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66902261 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66398440 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.64966629 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64715787 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64388788 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.64369865 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.63795545 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63773509 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63629235 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62953821 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62603456 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62597607 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61099500 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61057391 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60984212 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60200607 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60123484 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60056602 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59859712 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59807466 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59717646 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59291918 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58860241 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58559110 |
| 121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.58384958 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58381935 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58136494 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58135455 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58135042 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.57509799 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57508532 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57352752 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57160049 |
| 130 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57036691 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57023324 |
| 132 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55626580 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53905387 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.52782590 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52597687 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51285231 |
| 137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51002893 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.49684692 |
| 139 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46214236 |

